Clinical Trial Update: Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study [Phase 3]

View source ↗

Summary

This document reports the results of an extension Phase 3 study evaluating the efficacy of the GSK 580299 HPV vaccine in Japanese women who were part of the pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• GSK 580299 vaccine (human papillomavirus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2012-10-15